Related references
Note: Only part of the references are listed.Boosters for adeno-associated virus (AAV) vector (r)evolution
Joanna Szumska et al.
CYTOTHERAPY (2023)
Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A
Sylvia Fong et al.
NATURE MEDICINE (2022)
Vector genome loss and epigenetic modifications mediate decline in transgene expression of AAV5 vectors produced in mammalian and insect cells
Britta Handyside et al.
MOLECULAR THERAPY (2022)
Fantastic AAV Gene Therapy Vectors and How to Find Them-Random Diversification, Rational Design and Machine Learning
Jonas Becker et al.
PATHOGENS (2022)
AAV vectors: The Rubik's cube of human gene therapy
Amaury Pupo et al.
MOLECULAR THERAPY (2022)
Epigenetic Silencing of Recombinant Adeno-associated Virus Genomes by NP220 and the HUSH Complex
Anshuman Das et al.
JOURNAL OF VIROLOGY (2021)
Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A
Lindsey A. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
High-Throughput In Vitro, Ex Vivo, and In Vivo Screen of Adeno-Associated Virus Vectors Based on Physical and Functional Transduction
Adrian Westhaus et al.
HUMAN GENE THERAPY (2020)
MV Capsid-Promoter Interactions Determine CNS Cell-Selective Gene Expression In Vivo
Sara K. Powell et al.
MOLECULAR THERAPY (2020)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
CUT&Tag for efficient epigenomic profiling of small samples and single cells
Hatice S. Kaya-Okur et al.
NATURE COMMUNICATIONS (2019)
Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors
Katja Pekrun et al.
JCI INSIGHT (2019)
PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression
Yi-Zi Zheng et al.
CANCER RESEARCH (2018)
Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity
Nicole K. Paulk et al.
MOLECULAR THERAPY (2018)
A 5′ Noncoding Exon Containing Engineered Intron Enhances Transgene Expression from Recombinant AAV Vectors in vivo
Jiamiao Lu et al.
HUMAN GENE THERAPY (2017)
Enhancing Transgene Expression from Recombinant AAV8 Vectors in Different Tissues Using Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element
Lizheng Wang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2016)
An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses
Claire A. Schreiber et al.
PLOS PATHOGENS (2015)
Adeno-Associated Virus Capsid Proteins May Play a Role in Transcription and Second-Strand Synthesis of Recombinant Genomes
Maxim Salganik et al.
JOURNAL OF VIROLOGY (2014)
Selection and evaluation of clinically relevant AAV variants in a xenograft liver model
Leszek Lisowski et al.
NATURE (2014)
Minicircle DNA Vectors Achieve Sustained Expression Reflected by Active Chromatin and Transcriptional Level
Lia E. Gracey Maniar et al.
MOLECULAR THERAPY (2013)
Regulation of chromatin by histone modifications
Andrew J. Bannister et al.
CELL RESEARCH (2011)
In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses
Dirk Grimm et al.
JOURNAL OF VIROLOGY (2008)
Adeno-associated virus vector Genomes persist as episomal chromatin in primate muscle
Magalie Penaud-Budloo et al.
JOURNAL OF VIROLOGY (2008)
The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription
Erica Cavellan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Adeno-associated virus serotypes: Vector toolkit for human gene therapy
Zhijian Wu et al.
MOLECULAR THERAPY (2006)
Adeno-associated virus: from defective virus to effective vector
Manuel A. F. V. Goncalves
VIROLOGY JOURNAL (2005)
Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo
H Nakai et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
